Structure, Pharmacology, and Clinical Use of Antifibrinolytic Agents

Samama, Charles Marc; Dietrich, Wulf; Horrow, Jan C.; Taby, O.; Samama, M

doi:10.1007/978-3-642-56637-0_21

Cited by 5 publications

(1 citation statement)

References 142 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It develops a broad inhibitory specificity on serine protease but its most important effect is to inhibit plasmin, trypsin and kallikreins of different origins. 19 It forms a stochiometric complex and blocks the active site of the enzyme. It is a competitive inhibition.…”

Section: How Does Aprotinin Work?mentioning

confidence: 99%

Aprotinin and Major Orthopedic Surgery

Samama

2004

Transfus Alt Transfus Med

View full text Add to dashboard Cite

SUMMARY Aprotinin is a potent pharmacological agent which reduces bleeding and limits blood transfusion in current surgical practice. Many studies have been conducted in orthopedic surgery. Several trials have been performed in total hip replacement and total knee replacement patients, and aprotinin only moderately decreased blood loss requirements in these patients. Conversely, when aprotinin was used in patients with a high bleeding risk (cancer, sepsis, redo surgery, etc.), it developed a potent hemostatic activity and significantly decreased transfusion requirements. No increase in deep vein thrombosis and pulmonary embolism was observed. The only major side effect could be the potential occurrence of an anaphylactoid reaction. Prophylactic administration of aprotinin should be considered in extensive spine surgery and in high‐risk major orthopedic operations. The decision to use aprotinin will be guided by a risk/benefit analysis.

show abstract

Section: How Does Aprotinin Work?mentioning

confidence: 99%